U.K. Launch Delays Under NICE Predicted By Rx Industry
Executive Summary
Pharmaceutical launches could be delayed by two or more years under the U.K.' s recently implemented National Institute for Clinical Excellence, Glaxo Wellcome Corporate Affairs Director and Association of the British Pharmaceutical Industry President Michael Bailey maintained at a London press conference April 7.